This study comprehensively and systematically analyzed the prognostic value, genetic variation, and signaling pathways of PTBP1, PTBP2, and PTBP3 and the correlation of PTBP expression with TILs, ICP, TMB, MSI, and drug sensitivity from a pan-cancer perspective. The gene discussed is PTBP3; the disease is cancer.